Cargando…

Formulation and in vitro Evaluation of Alfuzosin Extended Release Tablets Using Directly Compressible Eudragit

The aim of the present study was the determination of formulation factors and the in vitro evaluation of an extended release dosage form of a freely soluble weakly basic drug (alfuzosin hydrochloride). Binary mixer of one hydrophilic polymer (hydroxypropylmethylcellulose) and one directly compressib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roni, M. A., Kibria, G., Jalil, R.
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2009
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865782/ https://www.ncbi.nlm.nih.gov/pubmed/20490290 http://dx.doi.org/10.4103/0250-474X.56019

Ejemplares similares

In Vitro-In Vivo Correlation Evaluation of Generic Alfuzosin Modified Release Tablets
por: Sanki, Utpal Kumar, et al.
Publicado: (2012)

Development and Characterization of Eudragit(®)-Based Electrospun Nanofibrous Mats and Their Formulation into Nanofiber Tablets for the Modified Release of Furosemide
por: Vlachou, Marilena, et al.
Publicado: (2019)

Formulation and in vitro evaluation of Eudragit S-100 coated naproxen matrix tablets for colon-targeted drug delivery system
por: Mehta, Rohit, et al.
Publicado: (2013)

In vitro-in vivo evaluation of xanthan gum and eudragit inter polyelectrolyte complex based sustained release tablets
por: Deb, Tamal Krishna, et al.
Publicado: (2015)

Formulation and Evaluation of Once Daily Minocycline Hydrochloride Extended Release Matrix Tablets
por: Keny, R. V., et al.
Publicado: (2009)

Formulation and Evaluation of Trimetazidine Dihydrochloride Extended Release Tablets by Melt Congealing Method
por: Javeer, S. D., et al.
Publicado: (2010)

Development of In Vitro–In Vivo Correlation for Upadacitinib Extended-Release Tablet Formulation
por: Mohamed, Mohamed-Eslam F., et al.
Publicado: (2019)

Formulation Development and Evaluation of Drug Release Kinetics from Colon-Targeted Ibuprofen Tablets Based on Eudragit RL 100-Chitosan Interpolyelectrolyte Complexes
por: Ofokansi, Kenneth Chibuzor, et al.
Publicado: (2013)

Design and In Vitro Evaluation of Compression-coated Pulsatile Release Tablets of Losartan Potassium
por: Bajpai, M., et al.
Publicado: (2012)

Spectrophotometric Determination of Alfuzosin HCl in Pharmaceutical Formulations with some Sulphonephthalein Dyes
por: Ashour, Safwan, et al.
Publicado: (2006)

Eudragit(®) Microparticles for the Release of Budesonide: A Comparative Study
por: Cortesi, Rita, et al.
Publicado: (2012)

Formulation Development and Stability Studies of Norfloxacin Extended-Release Matrix Tablets
por: Oliveira, Paulo Renato, et al.
Publicado: (2013)

Acetylation and Evaluation of Taro Boloso-I Starch as Directly Compressible Excipient in Tablet Formulation
por: Getachew, Afewerk, et al.
Publicado: (2020)

Formulation and Evaluation of Cephalexin Extended Release Matrix Tablets Using 3(2) Factorial Design
por: Jishnu, V, et al.
Publicado: (2011)

Design and evaluation of an extended-release matrix tablet formulation; the combination of hypromellose acetate succinate and hydroxypropylcellulose
por: Fukui, Sachiko, et al.
Publicado: (2017)

Formulation, characterization and evaluation of the effect of polymer concentration on the release behavior of insulin-loaded Eudragit(®)-entrapped mucoadhesive microspheres
por: Kenechukwu, Franklin C., et al.
Publicado: (2016)

QbD based Eudragit coated Meclizine HCl immediate and extended release multiparticulates: formulation, characterization and pharmacokinetic evaluation using HPLC-Fluorescence detection method
por: Qazi, Faaiza, et al.
Publicado: (2020)

A synchronous spectrofluorometric technique for simultaneous detection of alfuzosin and tadalafil: applied to tablets and spiked biological samples
por: Elama, Heba Samir, et al.
Publicado: (2022)

Formulation, in vitro characterization and optimization of taste-masked orally disintegrating co-trimoxazole tablet by direct compression
por: Tafere, Chernet, et al.
Publicado: (2021)

Studies on Formulation and In Vitro Evaluation of Floating Matrix Tablets of Domperidone
por: Prajapati, S. T., et al.
Publicado: (2009)

Influence of Formulation Factors and Compression Force on Release Profile of Sustained Release Metoprolol Tablets using Compritol(®) 888ATO as Lipid Excipient
por: Patere, Shilpa N., et al.
Publicado: (2015)

Preparation and Evaluation of Directly Compressible Orally Disintegrating Tablets of Cannabidiol Formulated Using Liquisolid Technique
por: Limpongsa, Ekapol, et al.
Publicado: (2022)

Evaluation of Gum of Moringa oleifera as a Binder and Release Retardant in Tablet Formulation
por: Panda, D. S., et al.
Publicado: (2008)

Development and evaluation of natural gum-based extended release matrix tablets of two model drugs of different water solubilities by direct compression
por: Ofori-Kwakye, Kwabena, et al.
Publicado: (2016)

Formulation and In Vitro, In Vivo Evaluation of Effervescent Floating Sustained-Release Imatinib Mesylate Tablet
por: Kadivar, Ali, et al.
Publicado: (2015)

Assessing Palatability of a New Amphetamine Extended-Release Tablet Formulation for the Treatment of ADHD
por: Pardo, Antonio, et al.
Publicado: (2021)

Flurbiprofen alone and in combination with alfuzosin for the management of lower urinary tract symptoms
por: Gokkaya, Cevdet Serkan, et al.
Publicado: (2015)

Eudragit nanoparticles containing genistein: formulation, development, and bioavailability assessment
por: Tang, Jingling, et al.
Publicado: (2011)

Formulation, evaluation and optimization of sustained release matrix tablets of captopril
por: Pandya, V. Pandya, et al.
Publicado: (2012)

Formulation and evaluation of bilayer tablet for bimodal release of venlafaxine hydrochloride
por: Momin, Munira M., et al.
Publicado: (2015)

Correction: Formulation and In Vitro, In Vivo Evaluation of Effervescent Floating Sustained-Release Imatinib Mesylate Tablet
Publicado: (2022)

Formulation and Evaluation of Cephalexin Extended-release Matrix Tablets Using Hydroxy Propyl Methyl Cellulose as Rate-controlling Polymer
por: Vijay, J, et al.
Publicado: (2012)

Preparation and Evaluation of Mixture of Eudragit and Ethylcellulose Microparticles Loaded with Ranolazine for Controlled Release
por: Gowda, DV, et al.
Publicado: (2011)

Development and bioequivalence study of potassium chloride extended release tablets
por: Le Thi, Thu Van, et al.
Publicado: (2018)

Sustainable Stabilizer-Free Nanoparticle Formulations of Valsartan Using Eudragit(®) RLPO
por: Hajba-Horváth, Eszter, et al.
Publicado: (2021)

Investigating the role of excipients on the physical stability of directly compressed tablets
por: Maclean, Natalie, et al.
Publicado: (2021)

A Directly Compressible Pregelatinised Sago Starch: A New Excipient in the Pharmaceutical Tablet Formulations
por: Widodo, Riyanto Teguh, et al.
Publicado: (2022)

Studies on Flowability, Compressibility and In-vitro Release of Terminalia Chebula Fruit Powder Tablets
por: Satya Prakash, Singh, et al.
Publicado: (2011)

Formulation of Modified-Release Bilayer Tablets of Atorvastatin and Ezetimibe: An In-Vitro and In-Vivo Analysis
por: Mubeen, Iqra, et al.
Publicado: (2022)

Alfuzosin for chronic pelvic pain syndrome: Another placebo?
por: Nirmal, T. J., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_mb0j674r4sqdpn37km1u4jcm23